....

Size: px
Start display at page:

Download "...."

Transcription

1 Vol. 22 No

2 1/2 EE F FAF 60E FIP cx 60 10M5 Vol. 22 No

3 carpal tunnel syndrome entrapment neuropathy cm 4 Vol. 22 No

4 5 Vol. 22 No microglobulin 1/2 1/2 night tingling 1 myxedema 2 3 double lesion neuropathy night tingling

5 de Quervain Tinel Tinel Tinel Phalen perfecttest Tinel90 98 Phalen83 tourniquet test60 21 median nerve compression test Vol. 22 No

6 7 Vol. 22 No X CTMRI cm 4.5msec 3.5msec subclinical double lesion neuropathy X MRI B12 10 perfectotest) O

7 8 Vol. 22 No ml 1290 Camitz Camitz Camitz

8 Entrapment neuropathy. MOOK , , Entrapment neuropathy. pp , pp , , pp , , , , pp , Vol. 22 No

9 R hemodialysis, HD peritoneal dialysis, PD /3 HD 17.7PD PD HDPD 2.0PD /3 PD HD1947 PD QOL PD Vol. 22 No

10 mOsm/kg Na 132 meq/l K 0.0 meq/l Ca 2.5 meq/l or 4.0 meq/l P 0.0 mg/dl BUN 0.0 mg/dl Cr 0.0 mg/dl continuous ambulatory peritoneal dialysis 24 L automated peritoneal dialysis PD cycle CAPD QOL nightly peritoneal dialysis R BaxterPD R Vol. 22 No

11 continuous cyclic peritoneal dialysis NPD NPD NPD NPD CAPD tidal peritoneal dialysis APD 50NPD CAPD CAPD24NPD HD HD PD 200ml 20kg 100ml/ PDPD HD CAPD2L1L Na 137 meq/l m Eq10g APDNaNa Na6090mEq/L Vol. 22 No

12 800 mg PD toxic shock shock PD PD HD PD PD D 75 high turn over bone D g g 1,25 PTHAlp low turn over bone D 14 Vol. 22 No

13 6.0mg/dL 4.0 CaCa4 8.0mg/dL D 8.5mEq/L Dry weight Ca ACE 50100ng/mL HD PD 100/kg Hb 300 /kg ACE IGF-I catch-up Department of Health & Human Services. United States Renal Data System.1999 Annual Data Report. Maryland, US. NIH, , CAPDII.. CAPD1990. Vol. 22 No

14 ddddddddddddddddddddddddddddddddddddddddddddd ddddddddddddddddddddddddddddddddddddddddddddd Vol. 22 No

15 T TT TTT 18 Vol. 22 No

16 T IMHC TTIMHC TIMHC T TTT Vol. 22 No

17 DNA DNA T DNADNA DNA T 20 Vol. 22 No

18 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 10Vol.20 No.10 Vol.21 No.3 10mg20mg40mg 20mg 20mg10mg 40mg Vol. 22 No

19 24 Vol. 22 No

20 25 Vol. 22 No ?

21 Vol. 22 No

22 DI REPORT 27 Vol. 22 No DI 50 mm P 21G 25 B P G B-D mg/dL mg/dL 1550L g H P 21G S P G B-D mg/dL 50L g H H S mg/dL L g H

23 DI REPORT M B-D 30G B-D 30G G G G DM mg/dL 20600mg/dL 20600mg/dL L L L mm g 60g 45g H H H Vol. 22 No

24 DI REPORT 29 Vol. 22 No mm B-D 30G G G G DM mg/dL L g H S S mg/dL g H N LNH 2.5mL mg/dL L g H

25 DI REPORT Z Inc. Inc Z LNH 3000 CROM mg/dL 500mg/dL 500mg/dL L 10L 10L mm g 102g H9. 6 H H H12. 2 H Vol. 22 No

26 DI REPORT QID G G ml mg/dL 20600mg/dL 20600mg/dL 3.5L L L mm g 18g 60g 95g H H H H H H H11. 2 H12. 1 H9. 6 H9. 2 H9. 2O/T No PRACTICE Vol. 15 No Vol. 22 No

27 4B 12 4B 32 Vol. 22 No

28 NHK 1973 Vol. 22 No

29 N.I.Vavilov 20 F.N.Meyer Augustin Pyrame de Candolle Vol. 22 No

30 to-mo to-mo Prunusplum persica Perusicum mālum Persicum presica pesca peschepeche pêche peche14peach16 Vol. 22 No

31 peach peche PfirsichPfirsichbaum Pesca Prunus persica(l.)batsch (Amygdalus persica L.) m 15cm 1.5cm cm kaempferol cumarin amygdalin24-24-methylencycloartanol 7-7 -avenasterol40 emulsin 1712 g 30g 500g 36 Vol. 22 No

32 1318 Vol. 22 No

33 Vol. 22 No

34 39 Vol. 22 No

35 TEL Vol. 22 No

36 OK 40OK OK OKOK OK Vol. 22 No

37 42 Vol. 22 No

38 43 Vol. 22 No PR A 12 OTC 10 OTC 3040

39 44 Vol. 22 No DI TDM TDM

40 45 Vol. 22 No TDM 480 1,500 G OTC100 OTC 100

41 46 Vol. 22 No OTC OTC OTC 1020 OTCH2 70 H2 OTC OTC

42 47 Vol. 22 No TDM TDM TDM TDM 10 EBM

43 48 Vol. 22 No OTC 21 10

44 49 Vol. 22 No AB

45 50 Vol. 22 No

46 50 Vol. 22 No

47 QOL CAPD Vol. 22 No

48 53 Vol. 22 No JA 56.4BC

49 54 Vol. 22 No

50 55 Vol. 22 No /4 14

51 Col N. et al : The role of medication noncompliance and adverse drug reaction on hospitalizations of the elderly. Arc Intern Med. 150 : , p. 217 Lamy PP. : Adverse drug effects. Clin Geriatr Med. 6 : , 1990 J Okuno et al. : Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmcol. 55 : , Vol. 22 No

52 Vol. 22 No

53 58 Vol. 22 No

54 59 Vol. 22 No ;; ;; ;; ;; ;; ;; ;; ;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;;;;; ;;;;;;; ;;;;;;; ;;;;;;;

55 60 Vol. 22 No a b c d 10 QOL

56 61 Vol. 22 No QOL OTC ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;;;;;;; ;;; ;;; ;;; ;;; ;;; ;;; ;;;

57 Vol. 22 No

58 65 Vol. 22 No JR10 1, JR10 3, JR ;; ;; ;; ;; DDDDDD DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

59 66 Vol. 22 No

60 68 Vol. 22 No PI , YMCA

61 69 Vol. 22 No Na Q&A 2, NKS Tel

62 70 Vol. 22 No , JR10 JR10 JR 21

M1 TSH T 3 T 4 2 T 1 2 Plummer 3 TSH TSH K 5 7 TSH TSH Plummer TSH TSH TSH TSH T 4 T 3 TSH T 4 T 3 TSH TSH or Plummer Plummer or a) 1. 2. 3. b) 1. T 4 T 3 2. TSH 0.1 U/ml 3. TSH TRAb TSAb 4. 1) a) 1

More information

DM

DM ( ) FAX DM DM PR 300 - - - - - - - - - - - - - - - - - - 6 3 1 4 3 - - - - PR P173 FAX (2001) (2000) (1999) 1986 http://kimono-yamato.com/04-kiso/qa.html Q&A http://web.sfc.keio.ac.jp/~t00524sh/chousa/rich/kimonobegin.html

More information

07.報文_及川ら-二校目.indd

07.報文_及川ら-二校目.indd 8 01 01 4 4 1 5 16 18 6 006 H 18 4 011 H 6 4 1 5 1 5 007 H 19 5 009 1 5 006 007 009 011 9 10 4 000 H 1 4 5 004 H 16 4 004 009 H 1 5 4 4 5 1 4 006 011 1 1 4m 5m 10m 007 1 7 009 009 1 5 10 1 000kg 10a 006

More information

紀要No.9_006王_CS.indd

紀要No.9_006王_CS.indd 1 2 3 4 5 87 9 2009 1937.1 6 1937.1 2 1937.3 1937.9 73 1941.6 77 1941.10 27 1943.9 1943.10 1944.12 1946.12 1947.1 5 1948.4 L 1949.9 10 1950.10 1953.1 1953.12 1956.5.16 1956.6 1966.9 30 1966.10 1967.4 1967.9

More information

48 * *2

48 * *2 374-1- 17 2 1 1 B A C A C 48 *2 49-2- 2 176 176 *2 -3- B A A B B C A B A C 1 B C B C 2 B C 94 2 B C 3 1 6 2 8 1 177 C B C C C A D A A B A 7 B C C A 3 C A 187 187 C B 10 AC 187-4- 10 C C B B B B A B 2 BC

More information

untitled

untitled Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb

More information

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI 20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old

More information

無印良品 2012 自転車 カタログ

無印良品 2012 自転車 カタログ 26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417

More information

4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2

4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5

More information

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742 MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2

More information

クレジットカード決済の導入による公金収納のサービス向上

クレジットカード決済の導入による公金収納のサービス向上 CONTENTS 1 2 3 4 5 6 18 2612 1 2 1 1. 8. 6. 4. 2.. 1 1996 97 98 99 2 1 2 JR NHK 19 3 4 2 2612 1 2 N28 2 4 6 8 1 26 5 21 2 4718246 3 66. 2.72.6 23. 264 47182 264 2 3 3 1 12 2 214 21 116 4 28 N373 N28 5

More information

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10 . (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1

More information

21 60 Vol. 21 No

21 60 Vol. 21 No 3040 90 2 Vol. 21 No. 81999 21 60 Vol. 21 No. 81999 3 4444444444444444444444444444444444444444444444444444444 1830 10 12 1010 18 80 32 4 Vol. 21 No. 81999 Vol. 21 No. 81999 5 6 Vol. 21 No. 81999 Vol. 21

More information

取扱説明書 [F-12C]

取扱説明書 [F-12C] F-12C 11.7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 a bc b c d d a 15 a b cd e a b c d e 16 17 18 de a b 19 c d 20 a b a b c a d e k l m e b c d f g h i j p q r c d e f g h i j n o s 21 k l m n o p q r s a X

More information

C O N T E N T S 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 2009 Annual Report

C O N T E N T S 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 2009 Annual Report C O N T E N T S 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 2009 Annual Report 1 1 2009 Annual Report 1. 2. 2 2 2009 Annual Report 3 3 2009 Annual Report 3. 1980 1991 1992 1993 1994

More information

18年度石見美術館年報最終.indd

18年度石見美術館年報最終.indd A Annual Report Annual Report B 1 Annual Report Annual Report 2 3 Annual Report Annual Report 4 Annual Report 5 Annual Report 6 7 Annual Report Annual Report 8 9 Annual Report Annual Report 10 11 Annual

More information

1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15

More information

臨床神経 indd

臨床神経 indd 164 41 3 CTS CTS Key Words : carpal tunnel syndrome, nerve conduction study, sensory nerve action potential CTS CTS 10 1 2 CTS 1 3 4 CTS 1 Tinel Phalen Tinel CTS 1 Phalen Phalen Phalen Phalen 2 1/3 : 1

More information

2 5 28 4 1 47 2

2 5 28 4 1 47 2 4 4 5 28 1 2 5 28 4 1 47 2 10 10 22 78 10 28 2 2 10% NHK 30% 32% 3 4 5 1 150 1 5 1 20 2 3 1 2008 2 2 2009 2009 3 3 4 DNA 1 3 2 1 3 3 1 5 3 5 8 18 8 30 5 3 2 60 1 5 2 3 60 2 2 2 60 1 1 5 150 6 3 1 2 150

More information

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate 37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5

More information

3675-433897418-1.pdf

3675-433897418-1.pdf A : : : : : : : : : : PR PR NHK 2 PR PR 3 1954 7 4 5 9 12,000 12 100 2 2 11 4 5 6 7 / PR 8 9 10 11 1952 ( ) 2008 2009 2012 NHK km m m 12 m km km kg kg 13 % 14 15 1959 5 20 8 17100kg 400kg How much? 60

More information

1 P2 P P3P4 P5P8 P9P10 P11 P12

1 P2 P P3P4 P5P8 P9P10 P11 P12 1 P2 P14 2 3 4 5 1 P3P4 P5P8 P9P10 P11 P12 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 & 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1! 3 2 3! 4 4 3 5 6 I 7 8 P7 P7I P5 9 P5! 10 4!! 11 5 03-5220-8520

More information

23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213

More information

「若年不安定就労・不安定住居者聞取り調査」報告書

「若年不安定就労・不安定住居者聞取り調査」報告書 2008 3 2006 2007 3 19 6 7 5,400 2007 4 5 19 94 1 2 2007 5 i 2007 6 12 100 100 1 2 2008 3 ii 1960 1990 iii = 1990 = = iv 5 5 v & = 2 24 = 1990 10 vi vii i iii 1 3 1.1.............................................

More information

20-121

20-121 20 121 150 1 20 121 1 HbA1C 1 2 2 HbA1C 3 2 4 5 HbA1C 1 HbA1C -NH2 -CHO HbA1C 1 1 HbA1C HbA1C HbA1C HbA1C HbA1C 120 HbA1C HbA1C 1 2 2 HbA1C 120 10 10 10 3 β β 1 1 GAD ICA 2 4 HbA1C 2 1 2 5 2 20 121 150

More information

1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)

1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b) 2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)

More information

Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11

Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 Vol.170 2004.9.9 9 17 9 17 1000 8 10 9 17 14:00 17:00 30 28 Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 9.17 10 15 38 51 53 55 6 2

More information

DocuPrint C5450 ユーザーズガイド

DocuPrint C5450 ユーザーズガイド 1 2 3 4 5 6 7 8 1 10 1 11 1 12 1 13 1 14 1 15 1 16 17 1 1 18 1 19 1 20 1 21 1 22 1 23 1 24 1 25 1 26 27 1 1 28 1 29 1 30 1 31 1 2 12 13 3 2 10 11 4 9 8 7 6 5 34 24 23 14 15 22 21 20 16 19 18 17 2 35

More information

1 2 3 4 10 5 30 87 50 20 3 7 2 2 6 3 70 7 5 10 20 20 30 14 5 1,000 24 112 2 3 1 8 110 9 JR 10 110 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 25 30 31 32 25 A 33 B C D E F G PR PR or 34 35

More information

2005 6 7 15 2006 3 shokuiku shokuiku 2

2005 6 7 15 2006 3 shokuiku shokuiku 2 2005 6 7 15 2006 3 shokuiku shokuiku 2 shokuiku 3 (shokuiku) (shokuiku) (shokuiku) (shokuiku) 4 ( ) 2005 7 15 2006 4 5 shokuiku shokuiku 1 2 3 shokuiku shokuiku shokuiku 6 1 ( ) 15~64 1992 65 2050 40%

More information

untitled

untitled . 23 3 2 1 2 3 21 21 22 9 1 23 18 4 5 6 5 40 20 7 1 1 8 9 10 11 12 50cm 13 10 11 14 2011 3 11 15 16 ml mm tel 079-557-0039 & fax 079-557-1888 17 248-240- 98-48- 170-98- 98- ml 85-1,085-18 19 20 21 22 23

More information

140 120 100 80 60 40 20 0 115 107 102 99 95 97 95 97 98 100 64 72 37 60 50 53 50 36 32 18 H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 1 100 () 80 60 40 20 0 1 19 16 10 11 6 8 9 5 10 35 76 83 73 68 46 44 H11

More information

福岡大学人文論叢47-3

福岡大学人文論叢47-3 679 pp. 1 680 2 681 pp. 3 682 4 683 5 684 pp. 6 685 7 686 8 687 9 688 pp. b 10 689 11 690 12 691 13 692 pp. 14 693 15 694 a b 16 695 a b 17 696 a 18 697 B 19 698 A B B B A B B A A 20 699 pp. 21 700 pp.

More information

2015 1 4 5 6 8 10 16 17 18 Q&A 2 3

2015 1 4 5 6 8 10 16 17 18 Q&A 2 3 2015 1 AO 1 2015 1 4 5 6 8 10 16 17 18 Q&A 2 3 AO AO 21 AO 20 24 137 35 50 40 55 50 40 30 216 481 265 4 5 2015 1 AO 2015 2 A B 1 2 AB 2015 2 A B 1 2 AB 2015 2 A B 1 2 AB 2015 2 A B 1 2 AB 2015 AO AO A/

More information

労働法総論講義(2・完)

労働法総論講義(2・完) 173 174 175 176 .... 177 ............ NHK NHK.. NHK.................. 178 ........ 179 180 181 182 183 .. 184 185 186 187 .............. 188 .. 189 .. 190 .. 191 192 193 .. 194 195 196 .............. 197

More information

() 2

() 2 1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16

More information

1 ---------------------------------------------------------------------------- 1 ------------------------------------------------------------------------- 2 -------------------------------------------------------------------

More information

T1 T2 T3 T4-3- -4- -5- 11 11 12 12 12-6- -7- -8- -9- L 12-10- T T T T -11- 12 T1 T2 T3 T4 14 15 16 10 11 12 1 2 10 40 10 45 10 50 4 11 25 11 35 17 18 19 20 21 2.5cm T1 T2 T3 T4 T5 T6 T7 T8 22 23 24 25

More information

 

  10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2

More information

<82D282A982C1746F95F18D908F57967B95B E696E6464>

<82D282A982C1746F95F18D908F57967B95B E696E6464> 1 2 (90cm 70cm 2015) 3 (68cm 28cm 30cm 12kg 2015) (77.5 109.5cm 2015) 4 (22cm 50cm 50cm 4.6kg 2015) (45cm 62.5cm 2015) (47.4cm 62.5cm 2014) 5 (28.5cm 23.5cm) (45cm 62cm 2015) (97cm 107cm 2015) 6 7 8 9

More information

6 12 10661 93100 227213202 222208197 85kg cm 20 64.521 106856142 2 1 4 3 9767 100 35 cm 7747 208198 90kg 23 5828 10661 93100 cm 227213202 10639 61 64.521 85kg 78kg 70kg 61 100 197204.5 cm 15 61

More information

180 140 22

180 140 22 21 180 140 22 23 25 50 1 3 350 140 500cm 600 140 24 25 26 27 28 29 30 31 1/12 8.3 1/15 6.7 10 1/8 12.5 1/20 140 90 75 150 60 150 10 30 15 35 2,000 30 32 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 % 100 50 33.3

More information

合併後の交付税について

合併後の交付税について (1) (2) 1 0.9 0.7 0.5 0.3 0.1 2 3 (1) (a), 4 (b) (a), (c) (a) 0.9 0.7 0.5 0.3 0.1 (b) (d),(e) (f) (g) (h) (a) (i) (g) (h) (j) (i) 5 (2) 6 (3) (A) (B) (A)+(B) n 1,000 1,000 2,000 n+1 970 970 1,940 3.0%

More information

臨床神経45-1.indb

臨床神経45-1.indb 59 Case of the Issue No. 9 carpal tunnel syndrome: CTS CTS CTS CTS nerve conduction study; NCS needle electromyography; nemg NCS carpal tunnel syndrome: CTS 1 CTS 4 CTS 45 65 1 3 2 CTS CTS 1999 American

More information

1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3

1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3 201980Japan as number one 21American as number one 20 198020 19701980 1980 1990 2 Vol. 21 No. 111999 1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS

More information

国試過去問集.PDF

国試過去問集.PDF I 89 16 3 130 ab c AMPcAMP a 1 --- b c --- 2 --- --- 3 --- --- 4 --- --- 5 --- --- camp camp Ca 2+ β1 camp A camp camp A β1 p.156 β p.146 b. p.157 p135 (ANP) p157 c PDE-III p.157 p.157, 183 PDE C Ca PDE-III

More information

0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2

0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 24 11 10 24 12 10 30 1 0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 23% 29% 71% 67% 6% 4% n=1525 n=1137 6% +6% -4% -2% 21% 30% 5% 35% 6% 6% 11% 40% 37% 36 172 166 371 213 226 177 54 382 704 216

More information

10 117 5 1 121841 4 15 12 7 27 12 6 31856 8 21 1983-2 - 321899 12 21656 2 45 9 2 131816 4 91812 11 20 1887 461971 11 3 2 161703 11 13 98 3 16201700-3 - 2 35 6 7 8 9 12 13 12 481973 12 2 571982 161703 11

More information

21 3 1 1 1 2 3 3 3 4 10 14 17 18 20 21 35 41 47 48 48 49 49 54 59 59 63 67 72 86 86 87 88 88 88 89 90 94 115 8 20 6 1 2 266.5km 2 227.5km 2 85% 39.1km 2 15% 3 17,281 34.6% 4 5 6 14 20 %

More information

32 100 34 51 16,300

32 100 34 51 16,300 32 100 34 51 16,300 - 7 - - 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 1 3 3 5 5 B 6 2 2 4 4 6 10 - - 8 - - - 9 - 20 80 1/3 - - 10 - 0.7 0.9kg 21 147 70-11 - - 50 10cm 50 100 30cm kg 100

More information

10

10 2005 APR no.76 P P P P11P22 P2 P29 P30 P32 / / 787-8501 -10 TEL3-1111 FAX0120-59787 http//www.city.nakamura.kochi.jp/ http://www.city.nakamura.kochi.jp/i/ E-mailkouhou@city.nakamura.kochi.jp 10 10 10 29

More information

新入_本文.smd

新入_本文.smd 52 28 220 28 4 1 017-777-1511 2 2 8 2 9 8 9 47.2% 12.8% 11.5% 6.0% 4 2 (49.6%)(13.0%) (14.7%) (7.4%)(8.4%) (52.3%)(9.1%) (11.4%) (10.0%) 33.0% 23.4% 15.6% 9.6% (26.0%) (18.3%) (46.5%) (30.0%) (20.0%) 2

More information

緑化計画作成の手引き 26年4月版

緑化計画作成の手引き  26年4月版 http://www.city.shibuya.tokyo.jp/env/en_eventact/midori_ryokka.html 10 11 12 13 14 15 16 17 18 19 P10 P10 1 P12 2635 Fax (1) 47 03-5388-3554 http://www2.kankyo.metro.tokyo.jp/sizen/sinseisyo/e2/tebiki.htm

More information

近畿中国四国農業研究センター研究報告 第7号

近畿中国四国農業研究センター研究報告 第7号 230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15

More information

報告書

報告書 1 2 3 4 5 6 7 or 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 2.65 2.45 2.31 2.30 2.29 1.95 1.79 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 60 55 60 75 25 23 6064 65 60 1015

More information

I

I I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4

More information

(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..

(1) ) ) (2) (3) (4) (5) (1) (2) b (3).. ... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32

More information

取扱説明書 [F-02F]

取扱説明書 [F-02F] F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o

More information

ボトックス注用

ボトックス注用 2018 5 21 2017 1220 5 8 7 1 2 2 9 50 100 22100AMX00488 22100AMX00489 2009 9 2009 9 2009 2 1997 4 2016 6 2018 5 1989 12 1A 2 1 2 3 2 4 5) 1 100 1 2 3 4 A 1 50 50 0 45mg 0 25mg 100 100 0 9mg 0 5mg A 1 4mL

More information

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008

More information

PSCHG000.PS

PSCHG000.PS a b c a ac bc ab bc a b c a c a b bc a b c a ac bc ab bc a b c a ac bc ab bc a b c a ac bc ab bc de df d d d d df d d d d d d d a a b c a b b a b c a b c b a a a a b a b a

More information

untitled

untitled ........ ,..,..,..,,..,..,.. ,. , OECD ............ / :........................ :........ ... .. OECD OECD....... OECD Health Data ,, , :..... JR.... ,.. t-pa NICU ICU ICU.... NICU NICU NICU NICU.....

More information

QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12

QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12 54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34

More information

(事務局)

(事務局) 10. JR JR JR OK - 1 - JR.5 JR JR JR JR JR - 2 - NO1 IT 1.5 F PR - 3 - PR - 4 - JR - 5 - - 6 - - 7 - 8 45 JR 11-8 - 5 120 2 40 14 28 20 28 14 20-9 - 45 JR - 10 - JR JR JR JR JR JR JR JR JR JR JR JR JR JR

More information

thermometer AnnuAl RepoRt 2011 Terumo CorporaTion

thermometer AnnuAl RepoRt 2011 Terumo CorporaTion 2011 2011 3 1921 10 thermometer 1921 1853 1931 AnnuAl RepoRt 2011 Terumo CorporaTion 2011 5 01 Introduction MRS. GIeSeKe 1994 DuraHeart DuraHeartDuraHeart 5 DuraHeart DuraHeart DuraHeart duraheart 2007

More information

Taro10-名張1審無罪判決.PDF

Taro10-名張1審無罪判決.PDF -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -1- 39 12 23 36 4 11 36 47 15 5 13 14318-2-

More information

ml DNA DNA

ml DNA DNA ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED

More information

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

untitled

untitled 2303 16 2 9 1 14 5 31 (423) 1 (4), (6) C55H84ClN17O21S3 HCl (BLM-A2) 1487.47 11 2 1 4 104 2 14 5 31 [ ] ( ) ( ) 1. 15mg 30mg( ) 5 20mL 1 5mg( ) 2. 3 15mg 30mg( ) 5mL 1mg( ) 1mL 3. 5mg 15mg( ) 4. 1 2 1

More information

(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0

(1.2) T D = 0 T = D = 30 kn 1.2 (1.4) 2F W = 0 F = W/2 = 300 kn/2 = 150 kn 1.3 (1.9) R = W 1 + W 2 = = 1100 N. (1.9) W 2 b W 1 a = 0 1 1 1.1 1.) T D = T = D = kn 1. 1.4) F W = F = W/ = kn/ = 15 kn 1. 1.9) R = W 1 + W = 6 + 5 = 11 N. 1.9) W b W 1 a = a = W /W 1 )b = 5/6) = 5 cm 1.4 AB AC P 1, P x, y x, y y x 1.4.) P sin 6 + P 1 sin 45

More information

Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene

Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05

More information

1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61

1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61 1 2 2 ANCApouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - '03 2 3 31 UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, 3+ 4 14 156.0 cm 61.5 kg 36.9 158/92 mmhg 90 1. ANCA 2. 3. IgG4 deposit

More information

3 9 3 100 2 10 30 12 1 1 2 2 4 3 9 1 250-1- 3 12 2 2 4 2 16 2-2- -3-8 2 6 10 30 11 30 11 2,500 9 2 2 10-4- 2005 2005 5 50-5- 3 30 FM 43 18 23 730 1700 17 11 3 FM 2 1800 30 3 400 1 1 28 3 4 18.1.28-6- 1

More information

Understanding Stem Cell Transplant 2007

Understanding Stem Cell Transplant 2007 Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454

More information

/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1

/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1 11 1 -------------------- 19 205.117/205.128 14/15 205.126A/205.126B 16/17 COPD 18mcg COPD 11.1 11.1.1 COPD 100 19 205.227 COPD 1 FEV1.0 %FEV1.0 70% 1 FEV1.0 / FVC 70% 2 1 200 3 40 COPD 1 10mg ACE 1 1

More information

21 5 I C T J-Doit High risk Risk 20 7 21 34,324 30,858 38,735 26,800 27,490 20,472 18,533 20,096 14,913 14,931 488 470 491 435 446 10 t-pa intervention t-pa interventionclipping simulator subspecialty

More information

2010年愛知教育大学年次報告書

2010年愛知教育大学年次報告書 Annual Report Aichi University of Education 875 (3)1764 (5)2357 (8)4121 4.71 (2)1332 (4)1602 (6)2934 3.35 462 (2)578 (2)1040 439 (2)548 (2)987 643 1239 (1)1443 (1)2682 4.17 950 (1)1024 (1)1974

More information

12~

12~ R A C D B F E H I J K A A A A A A A A A A AD B C BD AD E A DB DB ADB D D DB BD A C D B F E AD B B B B BF AD B B DB B B B B DB B DB D D ADB D D D D D AB AD D DB AB B B B F D D B B D D BF DBF B B B FD

More information

p.01....

p.01.... 40 2 Vol. 22 No. 82000 10 10 12 21 Vol. 22 No. 82000 3 1858 13 1842 1862 1868 1871 1872 1836 4 Vol. 22 No. 82000 5 Vol. 22 No. 82000 1871 1869 10 12 187514 ü 6 Vol. 22 No. 82000 600 1,200 1020 100 18431883

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

untitled

untitled - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -

More information

経済論集 46‐1(よこ)(P)/2.三崎

経済論集 46‐1(よこ)(P)/2.三崎 1 1 14 2 1866 8 20 20 2 4 1871 20 3 4 2 1969 9 12 28 33 3 1970 35 5 1965 p.119. 1995 p.67 1960 p.86. 1965 p.120. 1927 p.5. 1942 p.127, p.129. 10 1877 7 12 16 6 10 7 10 1877 8 7 6 8 16 25 29 10 1877 9 1

More information

中高生を中心とした子供の生活習慣づくりに関する検討委員会 第3回 配付資料その3

中高生を中心とした子供の生活習慣づくりに関する検討委員会 第3回 配付資料その3 ( 2 1) 1)-1: 1025 20081367775 800mg 800mg800mg800mg 800mg800mg [Osami Akimitsu, Kai Wada, TerukiNoji, NozomiTaniwaki, MiladaKrejci, Miyo Nakade, Hitomi Takeuchiand Tetsuo Harada (2013) The relationship

More information

北アルプス_燕岳~穂高_-2.doc

北アルプス_燕岳~穂高_-2.doc 1 ( )22 2001 2226 30 1300m 27kg 2 JR 1000 22 10 3 500-400 au 300 N 2763m 4 N N 10 N 500m PM9:00 5 ( 2 ) 7 23 2001 2226 10 N N 40 10 30 6 5m N N N 12 3 49 30 20 2922m 7 K ( ) U S N ( ) 50 15 N 35 (2758m)

More information